Sugammadex for Reversal of Non-Depolarizing Neuromuscular Blockers UMEM Educational Pearls, 29 Dec 2015 After three failed attempts, the FDA finally granted approval for Merck's non-depolarizing neuromuscular blocker reversal agent…